Agenus Inc. (AGEN) Looks Strong as Stock Surges 11.15% - Tale of the Tape

Comment

Shutterstock photo


Agenus Inc. ( AGEN ) was a big mover last session, as the company saw its shares shoot up over 11% on the day. This significant rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $2.94 to $3.95 in the past one-month time frame, showed a pick-up yesterday at $3.39.


In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Agenus currently has a Zacks Rank #3(Hold) while its Earnings ESP is 0.00%.

Other attractive players in the healthcare industry include Actelion Ltd. ( ALIOF ) and Biogen Idec Inc. ( BIIB ) carrying a Zacks Rank #1 (Strong Buy) and Amicus Therapeutics, Inc. ( FOLD ) with a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 DaysClick to get this free report >>



Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AGENUS INC (AGEN): Free Stock Analysis Report

AMICUS THERAPT (FOLD): Free Stock Analysis Report

BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

ACTELION LTD (ALIOF): Get Free Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Investing Ideas , Stocks
More Headlines for: AGEN , FOLD , BIIB , ALIOF


More from Zacks.com

Subscribe






Zacks.com
Contributor:

Zacks.com

Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com